Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Encephalitis l: Introduction

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fasciculations Following COVID-19 Vaccination-A Case Series of Ten Patients.

Vaccines·2026

Same author

High-Affinity Human Germline and Mutated Autoantibodies Commonly Cross-React to Self-Antigens in 5 Subgroups of Autoimmune Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

Clinical Spectrum of Anti-SEZ6L2 Syndrome: A Case Report With Brain Volumetry and Systematic Literature Review.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

AMPAR immunization induces progressive autoimmune encephalitis with autoreactive B cells in the brain.

bioRxiv : the preprint server for biology·2026

Same author

The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Long-term memory reorganization of navigational episodes.

Nature human behaviour·2026

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Patient-Reported Outcome Measures in NMDA Receptor Encephalitis.

Josephine Heine¹, Ole Jonas Boeken¹, Sophia Rekers^1,2

¹Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology.

Neurology(R) Neuroimmunology & Neuroinflammation

|December 13, 2024

Summary

This summary is machine-generated.

Persistent neuropsychiatric symptoms and cognitive concerns significantly impact quality of life in N-methyl-D-aspartate receptor (NMDAR) encephalitis survivors. Coping strategies, not disease severity, predict long-term health-related quality of life (HRQoL).

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

Area of Science:

Neuroimmunology
Autoimmune Encephalitis
Neuropsychiatry

Background:

Long-term sequelae of N-methyl-D-aspartate receptor (NMDAR) encephalitis are not fully understood.
The impact of persistent symptoms on patients' subjective quality of life requires further investigation.

Purpose of the Study:

To evaluate postacute neuropsychiatric symptoms and subjective cognitive complaints in NMDAR encephalitis patients.
To identify predictors of health-related quality of life (HRQoL) in this patient population.
To assess disease coping mechanisms employed by survivors.

Main Methods:

Cross-sectional observational study of 50 postacute NMDAR encephalitis patients.
Utilized psychometric scales to assess neuropsychiatric symptoms (fatigue, sleep, anxiety, depression), HRQoL, independence, metamemory, and coping strategies.
Multivariable regression analyses were performed to identify HRQoL predictors.

Main Results:

Patients reported significantly higher anxiety, depressive symptoms, sleep disturbances, and fatigue compared to normative data.
Lower self-rated memory ability correlated with increased use of compensatory strategies.
Health-related quality of life (HRQoL) was predicted by affective symptoms, self-efficacy, and coping behaviors, not acute disease severity or physical disability.

Conclusions:

Persistent neuropsychiatric and cognitive issues are major contributors to reduced quality of life in NMDAR encephalitis.
Coping strategies play a crucial role in the neurorehabilitation and recovery of autoimmune encephalitis patients.
Findings support a patient-centered approach to postacute care, focusing on psychological and cognitive well-being.